WCG

WCG is a United States-based clinical research services and technology organization that works across the clinical trial lifecycle. Founded in 2012, the company brought together predecessor organizations with deep roots in independent ethical review, including the Western Institutional Review Board (WIRB), which was established in 1968 as the first organization of its kind dedicated to protecting the rights and welfare of patients in clinical trials. WCG describes its mission as improving lives by accelerating research, together, and positions itself as a partner that helps research teams overcome obstacles and bring new therapies to patients faster. The company serves sponsors, contract research organizations (CROs), sites and research institutions, and participants. Its service areas include ethical and scientific review, planning, design and feasibility, study and site enablement, and solutions for sites and research institutions. WCG also offers a technology platform called ClinSphere®, which combines industry-leading data, innovative technology, and human expertise to turn intelligence into impact. The company states that since its founding its end-to-end solutions have benefited more than 5,000 biopharmaceutical companies and CROs, 10,000 research sites, and several million patients. WCG's history through predecessor companies spans nearly 60 years. WIRB pioneered independent ethical review in 1968, three years before the National Institutes of Health required ethics review of human research and eight years before federal regulations demanded IRB review. Other predecessor organizations include Midlands IRB, founded in 1981 and known for early phase review, and New England IRB, founded in 1989 to provide regional ethical review support in Massachusetts. CenterWatch, acquired as part of WCG's history, became the first publisher of clinical trials information in 1994. These organizations form the foundation of WCG's current integrated offering. WCG continues to expand its capabilities through technology and acquisitions. Recent news includes the appointment of Anthony Doyle as Chief Financial Officer, the successful completion of an ISO 9001 audit, the acquisition of The Contract Network to extend ClinSphere's AI-driven site enablement capabilities, and the launch of ClinSphere Trial IntelX for smarter trial designs. The company also publishes industry reports such as the 2026 Trends and Insights Report and the 2025 Site Challenges Report, and it engages with the clinical research community through events including the SOCRA Annual Conference and SCOPE Europe.

WCG was founded in 2012 with the goal of systematically transforming drug development by addressing key critical pain points adversely affecting clinical trial performance. The company traces its legacy through predecessor organizations spanning nearly 60 years, during which it has embraced its role as a “Servant to Mankind.” At its core, WCG applies leading scientific knowledge and proprietary technology to advance life-saving innovations, aiming to improve the clinical trial process so that valuable therapies reach patients sooner and at lower cost. The earliest predecessor, the Western Institutional Review Board (WIRB), was founded in 1968 by Dr. Angela J. Bowen, a medical research pioneer, celebrated physician, and noted philanthropist. WIRB became the first organization of its kind dedicated to protecting the rights and welfare of patients involved in clinical trials. It was established three years before the National Institutes of Health required ethics review of human research, four years before the news media brought the Tuskegee study to public awareness, and eight years before federal regulations demanded IRB review of human research. This pioneering role in independent ethical review remains a cornerstone of WCG’s identity. In 1981, Midlands IRB was founded and soon became the leading specialist in Early Phase review. In 1989, New England IRB was founded to provide regional ethical review support in Massachusetts, now the largest R&D hub in the United States. In 1994, CenterWatch became the first publisher of clinical trials information, adding a valuable source of industry data and insights to the group’s capabilities. Since its founding in 2012, WCG has integrated these predecessor organizations into an end-to-end solutions platform. The company reports that its solutions have benefited more than 5,000 biopharmaceutical companies and CROs, of which 4,000 are small and mid-cap biopharmaceutical companies, as well as 10,000 research sites and several million patients. WCG’s offerings now span ethical and scientific review, planning, design and feasibility, study and site enablement, and solutions for sites and research institutions, all supported by its ClinSphere® technology platform. In recent years, WCG has continued to expand through innovation and acquisitions. The company appointed Anthony Doyle as Chief Financial Officer to support continued growth and operational scale. It successfully completed an ISO 9001 audit, reaffirming its enterprise-wide commitment to quality across clinical research. WCG announced the acquisition of The Contract Network to extend ClinSphere’s AI-driven site enablement capabilities across study start-up. It also unveiled ClinSphere® Trial IntelX, raising the bar for smarter trial designs, fewer amendments, and faster outcomes. WCG publishes industry reports such as the 2026 Trends and Insights Report and the 2025 Site Challenges Report, and it engages with the clinical research community through events including the SOCRA Annual Conference and SCOPE Europe.

• 2012

  WCG is founded with the goal of systematically transforming drug development.

• 1994

  CenterWatch becomes the first publisher of clinical trials information.

• 1989

  New England IRB is founded to provide regional ethical review support in Massachusetts.

• 1981

  Midlands IRB is founded, soon to become the leading specialist in Early Phase review.

• 1968

  Western Institutional Review Board (WIRB) is founded by Dr. Angela J. Bowen, pioneering the concept of independent ethical review.

WCG positions itself as a partner across the full research lifecycle, combining experience, data, and innovative technology to help research teams make better decisions, reduce bottlenecks, and bring therapies to patients faster. Its mission is to improve lives by accelerating research, together.

• ClinSphere®

  Industry-leading data, innovative technology and human expertise come together to turn intelligence into impact.

• ClinSphere® Trial IntelX

  Raising the bar for smarter trial designs, fewer amendments and faster outcomes.

• Ethical & Scientific Review

  Rely on expert, independent judgment, built around your study.

• Planning, Design, & Feasibility

  Design with evidence to deliver trials that work in the real world.

• Study & Site Enablement

  Unblock bottlenecks with targeted support that keeps studies moving.

• Solutions for Sites & Research Institutions

  Turn complex protocols into activation-ready workflows.

• 2020.12.03

  Reported2020.12.03

  WCG announces acquisition of Trifecta Clinical[5]WCG宣布收购Trifecta Clinicalprnewswire.com

  WCG announced its acquisition of Trifecta Clinical, a provider of technology-enabled clinical trial solutions. Trifecta was to be known as WCG Trifecta and retain its leadership structure and locations.

• 2020.07.17

  Reported2020.07.22

  WCG 2019 Xi’an wins Red Dot Design Award[6]WCG 2019 西安获得红点设计大奖prnasia.com

  WCG 2019 Xi’an received an honorary award in the Brand & Communication Design category of the 2020 Red Dot Design Award, described as the first multi-event esports competition to receive the honor.

• 2020.01.23

  Reported2020.01.23

  WCG announces acquisition of Statistics Collaborative[7]WCG 宣布收购 Statistics Collaborativeprnewswire.com

  WCG announced its acquisition of Statistics Collaborative, a biostatistical consultancy. Statistics Collaborative staff will join WCG, and the business will be known as WCG Statistics Collaborative and become part of WCG's Scientific and Regulatory Review Division. Financial terms were not disclosed.

• 2019.11.08

  Reported2019.11.08

  WCG announced its acquisition of Waife & Associates[8]WCG宣布收购Waife & Associatesprnewswire.com

  WCG announced that it had acquired Waife & Associates, a clinical-trial management consultancy. Waife & Associates will continue operating independently and retain its Needham, Massachusetts headquarters; financial details were not disclosed.

Read more

1. 1WCG Clinical Services: Improving Clinical Trial Quality & Efficiencywcgclinical.com
2. 2History | WCGwcgclinical.com
3. 3Why Choose WCG? | About WCG Clinicalwcgclinical.com
4. 4WCG Company News | WCGwcgclinical.com
5. 5WCG宣布收购Trifecta Clinicalprnewswire.com
6. 6WCG 2019 西安获得红点设计大奖prnasia.com
7. 7WCG 宣布收购 Statistics Collaborativeprnewswire.com
8. 8WCG宣布收购Waife & Associatesprnewswire.com